Researchers have identified a potential breakthrough in diagnosing chronic traumatic encephalopathy (CTE), a progressive brain disease associated with repeated head injuries, particularly among football players and other contact-sport athletes. A newly identified blood biomarker could eventually help doctors detect the condition while patients are still alive, rather than relying solely on post-mortem examinations.
The research, led by Boston University and Banner Health, identified a blood protein called endogenously cleaved microtubule-binding region tau (eMTBR-tau) as a promising indicator of CTE-related brain damage. Currently, the condition can only be definitively diagnosed through an examination of brain tissue after death.
Michael Alosco, co-senior author of the study and co-director of clinical research at the Boston University chronic traumatic encephalopathy Center, described the findings as a potential game-changer, while emphasising that further validation is necessary.
Study Identifies Promising Blood Biomarker
Published in the Journal of the American Medical Association, the study examined 21 former football players who had provided blood samples during their lifetimes and subsequently donated their brains for research.
Participants had been involved in various Boston University research projects between 2008 and October 2026. Researchers compared their blood samples with post-mortem findings to examine the relationship between eMTBR-tau levels and chronic traumatic encephalopathy -related brain abnormalities.
Although the findings revealed a strong association, researchers stressed that the investigation remains at an early discovery stage.
Potential Impact on Treatment Research
If validated through larger studies, the blood test could significantly improve research into CTE treatments. Identifying the condition during life would help researchers select suitable participants for clinical trials and monitor how patients respond to potential therapies.
However, specialists emphasise that the test would initially complement other diagnostic methods rather than independently establish a definitive diagnosis.
Former Athlete’s Story Highlights Significance
One participant was Ron “Bogie” Edwards, a former college and professional football player who died aged 79. His son, Rogue Edwards, said his father’s contribution could potentially help millions of people.
Edwards had experienced progressive memory problems and dementia before his death. A subsequent autopsy revealed advanced CTE.
Understanding the Risks of chronic traumatic encephalopathy
Associated with repeated blows to the head, CTE can cause memory loss, impaired judgement and behavioural changes. There is currently no cure.
Researchers believe developing reliable methods for detecting the disease during life could represent an important step towards earlier intervention and future treatment development.
Also Read :- Closed-Loop Brain-Computer Interfaces Could Transform Treatment for Depression, Anxiety and PTSD






